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STUDY OF SALIVARY GLAND TUMOURS 
INTRODUCTION 
 
The salivary gland tumours form 6% of tumours of head 
and neck. Cancer arising in the salivary glands remains a 
challenging problem for the head the neck surgeon. The relative 
rarity of these cancer makes it difficult to study their biologic 
activity and response to therapy. The intricate anatomy of the 
facial nerve and the submandibular triangle present technical 
challenges in surgical dissection. The goal of surgery for salivary 
gland cancer is en-bloc resection of the cancer with clear 
surgical margins and minimal morbidity. (Ries et al., 1991). 
In the historical survey, little was written about the 
salivary glands up to the middle of the 17th century. In 1660, 
Neil Stenson discovered the parotid duct in sheep’s head and 
named it after him. Thomas Wharton in 1656 identified the 
submadibular duct and gland and Bartholinus in 1669, the 
sublingual gland. 
Early operations on the parotid gland were reported by 
Siebold in 1781. Samuel white of Hudson, New York is credited 
with the fist successful surgical removal of the parotid in 1808. 
The first attempt at Total Parotidectomy with preservation of the 
nerve was made by Codreanu in 1892. Blair in 1912, Sistrunk in 
1921 and Bailey in 1941 demonstrated various methods to 
protect the nerve. 
The first clinical description of a parotid tumour was by 
Kaltschmeid in 1772. A classification of salivary gland tumour 
based on gross morphology was advanced by Auguste Bernard 
in 1841. Further contribution to literature came from Virchow in 
1863, Minsen in 1874, Adson in 1923, Warthin in 1929, James 
in 1934, Radon in 1934 and Billroth 1959. Modern trends in 
conservative surgery was described by David Patey in 1965. 
 
 
 
 
 
 
 
  
 
 
AIM OF THE STUDY 
 
1. To study the age, sex incidence of salivary gland tumours. 
2. To study the incidence of benign and malignant tumours 
in parotid, submandibular, sublingual and in minor 
salivary glands. 
3. To study the role of Fine Needle Aspiration Cytology (FNAC) 
in the diagnosis of salivary gland tumours. 
4. To study the various modalities of treatment undertaken of 
salivary gland tumours and to study the operative 
morbidity and mortality for various procedures. 
 
 
  
 
 
 
SURGICAL ASPECTS OF SALIVARY GLANDS 
INTRODUCTION 
There are three pairs of major salivary glands (Parotid, 
Submandibular and Sublingual) in addition to the numerous 
minor salivary glands in the tongue, palate, cheeks and lips. 
EMBRYOLOGY 
Embryologically, the major gland and some of the minor 
glands, arise from the stomadeal ectoderm and most of the 
minor glands are derived from the pharyngeal endoderm. 
PAROTID GLAND 
The parotid gland is the largest of the salivary glands being 
purely serous in nature. It is a compound Alveloar gland 
situated below the external acoustic meatus between the ramus 
of the mandible and the sternomastoid. The anterior extension of 
the gland over the masseter is often detached and is known as 
the Accessory parotid which lies between the zygomatic arch and 
the parotid duct. 
The gland resembles an inverted three sided pyramid. The 
investing layer of deep cervical fascia splits between the angle of 
the mandible and mastoid process to enclose the parotid gland. 
It has superficial and deep lamina. A portion of the deep lamina 
extending between the styloid process and mandible, is 
thickened to form the stylomandibular ligament which separates 
the parotid fascia in this and incomplete, so there is extension of 
the parotid gland into paraphryngeal space, which may manifest 
as dumbbell tumour of the deep lobe of the parotid. 
Parotid has an apex, four surfaces (superior, superficial, 
anteromedial, and posteromedial) and three borders (anterior, 
posterior and medial). 
The apex overlaps the posterior belly of digastric through 
which the cervical branch of facial nerve and the two division of 
the retromandibular vein emerge. 
Superior surface (or) base of the pyramid is related to 
superficial temporal vessels and auriculo temporal nerve. 
Superfical surface is covered with superficial fascia, which 
contains anterior branches of the greater auricular nerve. 
The anteromedial surface is related to the masseter & 
branches of facial nerve. The posteromedial surface is related to 
mastoid process, styloid process, external and internal carotid 
arteries. 
RELATIONSHIP OF FACIAL NERVE TO PAROTID GLAND 
According to Bailey’s bilobar theory, the parotid gland is a 
bilobed structure with a larger superficial lobe and a smaller 
deep lobe connected by an isthmus with the facial nerve lying in 
a connective tissue plane separating the two lobes. 
David Pateys Facio-venous plane concept states that, the 
gland is separated into superficial and deep by the posterior 
facial vein and the facial nerve. But, Meckenzie demonstrated 
that even when a facial plane seemed to bisect the gland into 
two lobes, the nerve usually does not pass through the plane but 
seemed to penetrate the substance of one or other lobe. 
Winsten and Ward confirmed the unilobar structure and 
believed that rather than a “parotid sandwich” the nerve could 
be compared to the “Creeper Vine weaving into the meshes of a 
trellis work” parotid gland. 
The facial nerve after leaving the skull by passing out 
through the stylomastoid foramen, at a point 2.5 to 4 cm deep to 
the middle of the anterior border of mastoid process, the nerve 
passess into the gland. 
It passes around the neck of the condyle of the mandible 
and rapidly becomes superficial and divides into a upper 
temporofacial division and a lower cervicofacial divisions and 
subsequently into a number of branches, some of which may be 
interconnected (pes-anserinus – like the foot of a goose). The 
branches of facial nerve are temporal, zygomatic, buccal, 
mandibular and cervical. Before entering the gland it gives of the 
posterior auricular nerve and nerves to the stylohyoid muscle 
and posterior belly of digastric. 
STRUCTURES WITHIN THE PAROTID GLAND 
FROM MEDIAL TO LATERAL 
1. External Carotid Artery : In enters and gland through its 
posteromedial surface and divides into maxillary artery and 
superficial temporal artery. The maxillary artery leaves the gland 
through its anteromedial surface. Superfical temporal vessels 
emerge at the anterior part of superior surface. Posterior 
auricular artery may arise within the gland. 
2. Retromandibular Vein : It is formed within the gland by 
the union of superficial temporal vein and maxillary vein. In the 
lower part of the gland the vein divides into anterior and 
posterior divisions which emerge at the apex (lower pole of the 
gland. 
3. Parotid duct (Stenson’s duct) : It is 5cm long which 
begins deep to and behind the angle of the mandible. It curves 
upwards and forwards through and gland receiving interlobular 
ducts as it goes. It passes forwards across the masseter and 
turns around its anterior border to pierce the buccinator and to 
open into the mouth via a small papilla on the inside of the 
cheek, opposite the second upper molar tooth. 
SUBMANDIBULAR GLAND 
The submandibular gland fills the major portion of the 
digastric or submandibular triangle enclosed in a loose sheath of 
deep cervical facia. 
The gland rests against the structures forming floor of the 
triangle, the mylohyoid and hyoglossus muscles. The gland has 
two portions, a superficial lobe lying superficial to the mylohyoid 
and a deep lobe wrapping around the posterior border of the 
mylohyoid muscle. 
Between the gland and the hyoglossus are the lingual 
nerve, the submandibular ganglion and the hypoglossal nerve. 
The submandibular duct (Wharton’s duct) is about 5cms long, 
runs forward from the deep part of the gland to enter the floor of 
the mouth on a papilla, beside the frenulum of the tongue. 
The facial artery ascends in a deep groove on the posterior 
end of the gland and then turns downwards and laterally 
between the gland and the mandible to enter the face at the 
anterior border of masseter. The gland is a seromucinous gland. 
The venous drainage is both into the anterior facial vein 
and the venae commitantes of the lingual artery. 
SUBLINGUAL GLAND 
It lies superficially in the floor of the mouth covered only 
by the oral mucosa. The gland does not have a single large 
excretory duct, but has a series of ductules that open either into 
the floor of the mouth directly or into the submandibular duct. 
The submandibular duct thus serves both the glands. 
MINOR SALIVARY GLANDS 
Embryologically they are derived from the pharyngeal 
endoderm. 
Physiologically, they produce serous fluids which wash 
away the sapient materials from the taste buds, maintaining the 
receptivity for fresh gustatory stimuli. 
The minor salivary glands consist of small accumulation of 
glandular tissue situated mainly beneath the oral mucosa. They 
empty their secretions into the oropharynx by way of 
rudimentary ducts. Such salivary acini are scattered throughout 
the lining of the lips, buccal cavity, platate, nasopharynx, nose 
and paranasal sinuses. Batsakis recorded such salivary tissue in 
the body of the mandible, lower part of the neck, hypopharynx, 
middle ear, sternoclavicular joint and thyroglossal duct. 
They are most abundant in the hard palate. The minor 
salivary glands and the sublingual glands have short straight 
duct system and are seldom affected by inflammatory condition, 
but react to anything causing obstruction to the flow. If partial it 
leads to mucocele, if complete leads to atrophy of the gland. 
 
 
 
 
  
 
PHYSIOLOGY OF SALIVARY GLANDS 
SALIVARY FUNCTION AND REGULATORY MOLECULES 
Salivary 
Gland 
Regulator Second 
Messenger 
Effect 
Parotid Gland Acetylcholine 
α - adrenergic 
substances P 
β adrenergic 
VIP 
Ca++ 
 
 
AMP 
Production of 
Saliva, Enzyme 
Secretion, 
increases cell 
metabolism  
Secretion of 
enzymes, 
increases cell 
metabolism. 
Submandibular 
Gland 
ACH         
α - Adrenergic 
β adrenergic 
VIP 
 
Ca++ 
 
? c.AMP 
? c.AMP 
Production of 
Saliva 
 
Production of 
Mucin 
Potentiates Ach 
effects,  
Enhances blood 
flow 
 
Willams et al., 1984 
 
 
 
 
PATHOLOGY 
Salivary gland tumours are classified into different 
categories based on their histologic appearance. There are about 
six classifications. 
1. Foote and Frazel (1934) 
2. Patey’s (1965) 
3. Eneroth 1967 
4. WHO classification – Thackray 1972. 
5. Batsakis 1979 
6. Schwartz 
Baksakis and co-workers have described a classification 
system based on histo morophological criteria. Within this 
system the potential confusion and controversy regarding acinic 
cell and mucoepidermoid lesion is avoided by not considering 
them as tumours but rather as carcinoma. 
 
1. WHO CLASSIFICATION 
I.  Epithelial Tumours 
A.  Adenomas  
 1.  Pleomorphic adenoma (Mixed tumours) 
2. Monomorphic Adenomas 
 a.  Adenolymphoma 
 b.  Oxyphilic adenoma 
 c. Other types 
 B. Mucoepidermoid tumours 
 C. Acinic cell tumours 
 D. Carcinoma 
  1.  Adenoid cystic carcinoma 
  2.  Adenocarcinoma 
  3. Epidermoid carcinoma 
  4. Undifferentiated carcinoma 
  5. Carcinoma in Pleomorphic adenoma 
 
II. Nonepithelial Tumour 
1. Hemangioma 
2. Lymphangioma 
3. Neurofibroma 
BATSAKIS CLASSIFICATION 1979 
BENIGN LESIONS 
A. Mixed tumour (pleomorphic adenoma) 
B. Adenolymphoma (Warthin’s tumour) 
C. Oncocytosis Oncocytoma 
D. Monomorphic adenomas 
1. Basal cell adenoma 
2. Glycogen-rich adenoma and clear cell 
adenoma 
3. Others 
E. Sebaceous adenoma 
F. Sebaceous lymphadenoma 
G. Papillary ductal adenoma 
H. Benign lymphoepithelial lesion 
II. MALIGNANT LESIONS 
A. Carcinoma arising in or from a mixed tumour 
B. Mucoepidermoid carcinomas 
C. Hybrid basal cells adenoma / adenoid cystic 
carcinoma 
D. Adenoid cystic carcinoma 
E. Acinic cell Carcinoma 
F. Adenocarcinomas 
G. Oncocytic carcinoma (malignant carcinoma) 
H. Clear cell carcinoma 
I. Epithelial or myoepithelial carcinoma of intercalated 
ducts. 
J. Squamous cell carcinoma 
K. Undifferentiated carcinoma 
L. Miscellaneous (including sebaceous carcinoma, 
Stensen’s duct carcinoma, melanomas, and 
carcinoma ex lymphoepithelial lesions) 
M. Metastatic carcinomas 
 
HISTOGENESIS OF TUMOURS 
1. Multicellular Theory of Origin – Various cells in the functional 
salivary complex may give rise to different type of epithelial      
tumours. 
1.  Acinar cells - Acinic cell carcinoma 
2. Striated duct cell - Oncocytic tumours. 
3. Intercalated duct cells - Mixed tumours 
   Adenoid cystic carcinomas. 
4. Excretory duct elements - Mucoepidermoid tumour, 
   squamous cell carcinomas. 
II. Another theory of tumour histogenesis is called Basal 
Reserve cell or Progenitor cell theory. The basal cells of the 
excretory and intercalated ducts function as progenitor or 
reserve cells for more highly differentiated compoents. 
The myoepithelial cell has been implicated as the element 
of mixed tumour. This cell by virtue of its interaction with the 
epithelial component, provides the variable mesenchyme like 
component of the lesions. 
 
 
INCIDENCE OF SALIVARY GLAND TUMOUR 
Salivary gland tumours comprise 6% of all neoplasms in 
the head and neck. Minor salivary gland tumours are more in 
the West Indies. Malignant salivary tumours are prevalent in 
Eskimos (Wallance et al., 1963). Salivary gland tumour of palate 
is unduly frequent and malignant in Uganda and appears in 
young subjects. 
Approximately 75% of all salivary neoplasms arise in the 
parotid gland of which 80% are benign and 80% of the benign 
tumour are pleomorphic adenomas. 
Approximately 15% of salivary neoplasm arise in the 
submandibular salivary gland, of which 60% are benign and 
95% of the benign tumours are pleomorphic adenomas. 
10% of salivary neoplasms arise from minor salivary 
glands, of which only 40% are benign and all the benign 
tumours are pleomorphic adenomas. 
 
 
BENIGN LESIONS 
PLEOMORPHIC ADENOMA (BENIGN MIXED TUMOUR) 
It is the most common of all salivary gland tumour. The 
term benign mixed tumour was first proposed by Minsen in 
1874, to describe the two components of the tumour, 
mesenchymal and epithelial. The tumours are essentially benign 
but may recur locally if removal is incomplete and a small 
proportion less than 5% undergo malignant change sometimes 
after a very long intervan. 
Patey, et al., 1965. 
These tumours occur most commonly in young adults, the 
majority developing before the age of 40. Males and females are 
equally affected. The parotid gland is the commonest site of the 
tumour, and nearly 90% of all salivary plemorphic adenomas 
occur in parotid gland. 
Macroscopically the tumours is firm and lobulated with a 
well defined capsule surrounding it. Microscopically epthielial 
cells proliferate in strands and some take on a duct like 
arrangement other cells, probably of myoepithelial origin, 
proliferate in sheets. In parts of the tumour, a mucoid material 
is produced, producing a myxomatous appearance and then an 
appearance resembling cartilage in histological sections.   
 
The plemorphic adenoma is classified as benign but 
strands of tumour cells tend to penetrate the capsule of 
compressed gland substance and connective tissue which 
surrounds it. Further lobules of tumour attached only by a 
narrow neck of tissue may extend beyond the limits of the mass. 
For these reasons simple enucleation will leave residual 
neoplasm behind and result in potentially disastrous 
multicentric recurrence, as will rupture of the tumour during its 
removal. Less than 5% of cases undergo malignant changes, 
when is described as a carcinoma arising in pleomorphic 
adenoma. 
ADENOLYMPHOMA OR WARTHIN’S TUMOUR 
(PAPILLARY CYSTADENOMA LYMPHOMATOSUM) 
Warthin’s Tumour comprises 6 – 10% of all parotid 
tumours being the second most common benign tumour of the 
parotid gland. It is almost exclusively confined to the parotid 
gland. Very rarely it occurs in submandibular gland. It occurs 
between 4th and 7th decade with male predominance. Malignant 
transformation is rare. 
Lewis et al., 1999. 
It is well encapsulated. The epithelium is double layered 
and is markedly eosinophilic and the inner cells are columnar, 
Microscopically, multiple papillae filled with a lymphoid stroma 
are seen to be projecting into the cystic spaces. The lymphoid 
tissue found within this tumour resembles that of a lymph node. 
The origin of this tumour is controversial. Two theories are 
put forward to explain the origin of the tumour. (1). Development 
entrapment theory, where salivary inclusion in the lymph node 
becomes the tumour (2). Theory of Allerga which offers the 
possibility that the lymphocytic components represents an 
immune or hypersensitivity reaction towards epithelial portion of 
the tumour. Macroscopially, it is well encapsulated, partly cystic 
often exclude an opaque fluid not unlike pus. 
3. ONCOCYTOMA 
It forms 1% of tumour, occurring only in parotid gland. It 
is seen in the older age group. Macroscopically it reveals a 
smooth, firm, rubbery mass within the parotid tissue. 
Microscopically it contains round, plumps, granular eosinophilic 
cells with small indented nuclei. (Oncocytes). 
 
4. MONOMORPHIC ADENOMA 
Included in this group are the basal cell adenoma, clear 
cell adenoma and glycogen rich adenoma. It commonly occurs in 
minor salivary glands of the upper lip. Also, parotid gland is 
mostly involved. Rows of peripheral palisading cells with a thick 
basement membrance is the distinctive feature of this tumour. 
MALIGNANT NEOPLASMS 
1. MUCO-EPIDERMOID CARCINOMA 
It is the most common malignant tumour of the parotid 
gland. The tumour is slow growing and rarely metastasise to 
lymph nodes, lungs and skin. Some grow rapidly and are 
aggressive. It is harder than pleomorphic adenoma, but do not 
cause facial paralysis. It is composed of sheets and masses of 
epidermoid cells and clefts and cystic spaces lined by mucus 
secreting cells. High incidence of recurrence (15-60%) occurs 
after the surgery. 
2. ADENOID CYSTIC CARCINOMA (CYLINDROMA OR 
BASALIOMA) 
It is the most common malignancy in the submandibular 
gland. Even though there is no capsule, it is a circumscribed 
tumour. It also occurs in non-salivary glands like breast, 
lacrimal glands. 70% of cases arise in minor salivary glands 
(Spiro et al., 1975). 
It consists of myoepithelial cells and duct epithelial cells 
which occurs in two patterns. 1. Cribriform pattern with 
reticular network of small dark cells and cyst like spaces with 
mucin. 2. Solid pattern : No cyst like spaces are seen. 
It is an aggressive tumour with early invasion of nerve and 
bone, which explains the difficulty in eradicating this tumour 
despite the extent of excision. 
3. ACINIC CELL CARCINOMA 
It forms 1% of all salivary neoplasm and almost all occur 
in the parotid gland. The are composed of cells resembling those 
of serous acini. Female predominance and incidence in children 
are common. 
4. ADENOCARCINOMA 
Small dark staining cells with relatively low cytoplasm are 
seen. They are highly aggressive with high local recurrence and 
distant metastasis. It is most commonly seen in minor salivary 
glands, followed by the parotid gland. 
 
CLINICAL FEATURES 
Salivary gland tumours are generally slow growing. Parotid 
tumour present as asymptomatic mass either below the ear 
lobule and behind the ramus of the mandible or the cheek, lying 
below the zygomatic arch and on the masseter muscle. It may be 
firm or hard. Warthin’s tumour may be cystic, transilluminant. 
Pain is usually absent. Malignant tumours infiltrate sensory 
nerves earlier and produce vague pain in the distribution of 
greater auricular and auriculotemporal nerve distribution. 
Malignancy in suspected when there is short history, pain, rapid 
growth fixity to muscle or skin, nerve involvement, restriction of 
temporomandibular joint and enlargement of lymph node. 
In parotid deep lobe tumour may present intra orally 
pushing the tonsil medially. Mucosa over the lump will be freely 
mobile.  Facial nerve palsy either total or incomplete will occur 
in 8-26% of parotid malignancies. 
Submandibular gland tumour should be examined 
bimanually to differentiate if from lymphnode swelling. Minor 
salivary gland tumour may present as intra oral tumours. 
 
INVESTIGATION 
PLAIN X-RAY FILM 
It may show bony erosion 
SIALOGRAM 
Not very useful in diagnosis of tumours. If may show 
displacement of duct in benign tumours and irregularity in case 
of malignant tumours. Displacement of parotid duct in the case 
of intraglandular lesions will give a “Bell in hand” configuration. 
ANGIOGRAPHY 
When deep lobe tumours are suspected, it is useful. 
RADIOISOTOPE SCAN 
Scanning done with Technetium 99M pertechnetate shows, 
all the tumour to be cold except Warthin’s tumour which is 
“hot”. 
CT SCAN 
Provides precise anatomical details showing exact location 
of a mass in the gland. 
 
MRI 
MRI is useful in delineating the relationship between the 
parotid tumour and the facial nerve. 
TREATMENT  
All the parotid tumours except Warthin’s tumour should 
be excised with adequate margins of normal salivary tissue. 
Superficial parotidectomy is the treatment of choice for the 
benign as well as low grade malignant tumours. Warthin’s 
tumour can be enucleated. 
Total excision is the treatment of choice for all the 
submandibular neoplasms. Minor salivary gland tumour 
removal may sometimes require resection of adjacent bone. 
SURGICAL TECHNIQUE OF SUPERFICIAL 
PAROTIDECTOMY 
The main objective in superficial parotidectomy is 
preserving the facial N. 
IDENTIFICATION OF FACIAL NERVE 
Identification of the facial nerve can be done by two ways. 
1. By identifying trunk 
2. By Identifying peripheral branches. 
Identifying the trunk first has more advantages and 
chances of injuring the nerve is less, as the main trunk of the 
nerve is constant in position, can be easily identified. 
Sistrunk, Bailey and Hobsley identified the peripheral 
branch first, namely the mandibular branch. This method 
proved to be difficult, as some of the tumors are tightly wedged 
between bony walls of parotid compartment and give difficulty in 
exposing the trunk at the stylomastoid foramen. 
Riessner recommended dissection starting at the zygomatic 
arch for tumours just below the zygomatic arch. He 
demonstrated that the upper two branches of the nerve were 
more constant in position the were large in size at the level of 
zygoma and lay directly on the periosteum. So it was not 
necessary to go through salivary tissue to expose the nerves. 
SUPERFICIAL PAROTIDECTOMY 
Under general hypotensive anaesthesia the head of the 
operating table is elevated to promote venous drainage. A 
transparent adhesive is prepared. 
The incision starts at the top of the helix and dips in to the 
tragal notch continued inferiorly in front of the ear and turns 
back gently under the earlobe to 2.5cm above the tip of mastoid 
process. The incision is extended up to the greter hornu of 
hyoid. The skin flap is dissected of the parotid upto the masseter 
anteriorly (care taken to avoid damage to the Facial branches). 
The greater auricular nerve and the external jugular vein are 
identified and divided. The posterior belly of diagastric is traced 
of the retracting sternocleidomastoid up to the mastoid process. 
The dissection is carried along the perichondrium of the 
tragal cartilage which ends in a pointer, which points to the 
facial nerve          1cm medially and inferiorly. The bridge of 
parotid tissue over the facial nerve is elevated down to the 
diagastric musle. Hemostasis is secured using bipolar 
diathermy. Nerve is followed forwards which divides after 2 cm. 
The upper division is dissected out first, followed by the lower 
division. 
The parotid gland is dissected from the nerve and turned 
downwards. After the removal of the superficial lobe facial nerve 
is seen over the massester and retromandibular portion of the 
gland. After perfect hemostasis with bipolar diathermy or with 
adrenalin soaks, the wound is sutured in two layers with suction 
drains.  
 
 
TOTAL PAROTIDECTOMY 
It was indicated for deep lobe tumours and in low grade 
malignancies. 
The procedure is same as superficial parotidectomy until 
the extension between superficial and deep lobes becomes 
apparent. The attachment can be between the two division or 
below the lower division of facial nerve. In the first type 
dissection of superficial lobe from facial nerve should be from 
below upwards. In the second type only the lower division with 
its distal branches is dissected. Para pharyngeal space allow 
easy finger dissection. Retromandibular vein is always ligated. 
RADICAL PAROTIDECTOMY 
It is indicated in high grade malignancy with facial nerve 
infiltration especially in adenoid cystic carcinoma. This 
procedure consist of removal of tumour with facial nerve along 
with cuff of tissue around the parotid gland. This consist of 
platysma laterally, masseter muscle medially, posterior belly of 
digastric and stylohyoid the superiorly deep jugular nodes and 
associated fat inferiorly and the tip of the mastoid and a portion 
of the sternomastoid posteriorly. 
 
 
COMPLICATIONS AND TREATMENT 
1. FACIAL NERVE PARALYSIS 
Permanent Facial nerve paralysis is seen is 3-5% of cases 
and transient palsy is seen in 8-65% of cases. 
TREATMENT  
In case of accidental injury, the nerve is repaired primarily. 
If the Facial nerve is sacrificed, autogenous nerve grafting is 
performed using greater auricular nerve. 
Glossopharyngeal, accessory spinal and hypoglossal nerves 
can be used to anastomose with the peripheral facial nerve. 
Transfer of masseter for lower part and temporalis muscle 
for upper part of the face can be trained. Gille’s procedure with 
temporalis muscle to establish motor power for eyelids is also 
tried. 
2. FREY’S SYNDROME (AURICULO TEMPORAL  
SYNDROME) 
In this condition, there is flushing and sweating of the skin 
innervated by the auriculo temporal nerve, whenever salivation 
is stimulated. The condition may follow surgery on parotid and 
temporomandibular joint.  
It is thought that following injury to the auriculotemporal 
nerve, post ganglionic parasympathetic fibres from the otic 
ganglion become united to sympathetic nerves from the superior 
cervical ganglion destined to supply these vessels and glands of 
the skin. 
Antiperspirant can be used to treat this condition. When 
this produces severe inconvenience, infra tympanic section of 
Jacobson’s nerve (tympanic nerve running from the 9th nerve via 
superficial petrosal to the otic ganglion) with or without section 
of chorda tympani has good results. 
3. SALIVARY FISTULA 
This is an important complication which diminishes and 
disappears spontaneously after sometime. 
SURGICAL MANAGEMENT OF SUBMANDIBULAR 
TUMOURS 
SUBMANDIBULAR GLAND EXCISION  
Sub mandibular gland excision should be performed under 
General anesthesia. The incision about 5cm placed 2 – 3 cm 
below the inferior border of the mandible, carried down through 
the  platsyma. The capsule of the gland and surrounding soft 
tissue should be left intact over the gland when excision is 
carried out for a neoplasm. In this technique, the marginal 
mandibular nerve is at risk, so the facial vein and artery should 
be located, as close to the gland as possible immediately and 
after transaction should be elevated, superiorly to reflect the 
marginal mandibular nerve from the field. The gland and 
surrounding soft tissue should be dissected from the under 
surface of the mandible. 
The inferior border of the gland is then elevated from the 
digastric muscle. The facial artery, if transected superiorly will 
again be transected posterolaterally, as one near its origin from 
the external carotid artery. The gland is reflected laterally to 
expose the mylohyoid muscle. 
As the free edge of the mylohyoid muscle is retracted, the 
lingual and hypoglassal nerves and Wharton’s duct are 
identified. The lingual nerve is the parasympathetic supply to 
the gland, with the apex at the mid point of the gland. 
The Wharton’s duct lies inferior to the lingual nerve and 
the hypoglossal nerve is more inferior, which is identified by an 
accompanying vein, the ranine vein. When all the structures are 
identified, the duct and branch of the lingual nerve to the gland 
are ligated and transected. The gland and contiguous soft tissue 
may be dissected free and removed. A rubber drain is inserted 
deep to the platysma and the wound is closed in layers. 
In case of tumours which is locally invasive, the lingual, 
hypoglassal and marginal mandibular nerve, the floor of the 
mouth, tongue, mandible and skin may be included in resection. 
 
COMPLICATIONS FOLLOWING SUBMANDIBULAR GLAND 
EXCISION 
1. Seroma 
2. Injury to cervical branch of facial nerve : 6-9 months 
should elase before offering treatment. If residual weakness 
persist, division of the equivalent branch on the other side will 
help to equalize the tone. No functional defect results. 
3. Injury to lingual and hypoglassal nerves will result in little 
deformity and there is no specific treatment. 
 
 
SURGICAL MANAGEMENT OF MINOR SALIVARY GLAND 
TUMOURS 
80 – 90% occur within the buccal cavity the commonest 
site being hard palate. 60% are cylindromas which are locally 
invasive and also metastasize late. 40% are mixed tumours. 
Preliminary biopsy is advised to establish the diagnosis. The 
treatment of choice is, radical excision including a wide margin 
of healthy tissue including mucosa and even bone using 
diathermy for hemostasis. 
The expirpation of oral neoplasm must be planned on an 
individual basis in each instance. Closure in lip, buccal area, 
floor of mouth and tongue, can generally be effected by primary 
suture. Defects in the palate, that do not penetrate the full 
thickness can be left open to granulate and heal by secondary 
intention. Larger defects require local or transferred mucosal or 
skin flaps. Through and through palatal losses necessitate use 
of dental prosthesis. Paranasal salivary tumours are treated by 
maxillectomy via the usual Weber Ferquson Cheek Flap. When 
regional lymphnodes are involved the Radical dissection is 
performed. Post operative irradiation is advocated for all 
malignant tumours. 
 
 ROLE OF NECK DISSECTION IN SALIVARY TUMOURS 
There is different of opinion concerning the indication for 
neck dissection in salivary gland carcinoma. Eneroth and 
Hamberger advocate elective neck dissection in all cases of 
salivary gland cancer, except in low grade mucopidermoid 
carcinoma. 
Sinha and co-workers recommended neck dissection only 
in clinically apparent metastasis. 
Maccomb et al., did not recommend elective neck 
dissection for parotid cancers but advised neck dissection for 
malignant tumours of submandibular gland since he 
demonstrated lymphnode metastasis in 43.7% of submandibular 
tumours and only 23% in parotid tumour. 
ROLE OF RADIOTHERAPY 
Fletcher and co-workers recommended adjuvant radiation 
therapy for high grade cancers and those patients with residual 
cancer to reduce the local failure rate. But there was no survival 
advantage for these patients. 
 In adenoid cystic carcinoma where there is perineural  
spread, local recurrence rate of 24 – 54% following surgery 
alone, was reduced to 14% when surgery is combined with post 
operative irradiation (Spiro et al., 1975) 
So the indications for Radiotherapy are as following  
1. Presence of locally aggressive cancer. 
2. Perineural spread of tumours 
3. Cervical metastatic disease 
4. Positive surgical margins. 
5. Cancer close to the facial nerve. 
6. High grade or recurrent tumour 
Pre operative radiotherapy in doses of 1200 to 3500 rad is 
very helpful to reduce the tumour size in radiosensitive tumours 
viz. adenoid cystic tumours and acinic cell tumours. 
ROLE OF CHEMOTHERAPY 
The salivary glands are moderately sensitive to 
chemotherapy durgs. Adenocarcinoma like tumours (adenoid 
cystic, Adenocarcinoma, acinic cell tumours) respond well to 
adriamycin, cisplatinum and 5FU. The squamous cell carcinoma 
and mucoepidermoid tumour respond well to methotrexate and 
cisplatinum. The overall response rate was 42%. There was 
regression mainly of local regional disease. 
PROGNOSIS 
Depends upon a number of factors 
1. Histological types 
Adenoid cystic cancers and malignant mixed tumours have 
a better prognosis. Squamous cell carcinoma, Adenocarcinoma, 
mucoepidermoid, undffierentiated carcinoma all have a poor 
prognosis. 
2.  Facial nerve involvement  
Patients presenting with facial palsy have poor prognosis. 
3.   Lymph nodal enlargement has poor prognosis 
 
 
REVIEW OF LITERATURE 
 
Salivary gland tumours are uncommon, and their 
epidemiology has not been well described. Salivary gland 
tumours account for only 6% of head and neck cancer and 0.3% 
of all cancer (Ries et al., 1991).  
Mixed pleomorphic adenomas are more common in 3rd or 
4th decade and more prevalent in women. 
Warthin’s tumours has a strong predilection for males with 
a male : Female ratio 5:1, it usually occurs in patients over 40 
yrs of age. 
Monomorphic adenomas occurs on an average in patients 
over the age of 60. 
AGE INCIDENCE 
Witt 1999 
Age 
No (59) % 
11 – 20 2 3 
21 – 30 2 3 
31 – 40 10 17 
41 – 50 10 17 
51 – 60 17 29 
61 – 70 13 22 
>70 5 8 
 
According to this study, the parotid tumour occur mostly 
in 3rd-7th decade. 
SEX INCIDENCE 
ASTOR 2002 
N=51 Types 
Male Female 
Benign 
Benign Mixed Tumour 2 16 
Warthin’s tumour 6 2 
Monomorphic adenoma 3 - 
Inflammatory 1 5 
Lipoma 1 - 
                             Sub Total 13 23 
Malignant 
Squamous cell carcinoma 5 1 
Adeno Carcinoma 3 2 
Lymphoma 1 1 
Merkel Cell Carcinoma 1 - 
Basaloid Neoplasm 1 - 
                             Sub Total 11 4 
                              Total 24 27 
 
 
According to the study, the benign tumours are more 
prevalent in females. Warthin’s tumour is more common in 
males. Carcinoma is more common males. 
HISTOPATHOLOGICAL FINDINGS OF PAROTID GLAND 
TUMOUR 
Hugo 
1973 
N=914) 
Witt 
1999 
N=53 
Pinkston 
and Cole 
1999 
N=212 
Vargas 
PA et al  
2002 
N=88 Classification 
No % No % No % No % 
Pleomorphic 
adenoma 
8 4 17 32 113 53 58 66 
Warthin’s tumour 18 9 19 36 60 28 13 14 
Mucoepidermoid Ca - - 1 2 19 9 9 10 
Adenoid Cystic Ca 12 6 - - 1 0.5 - - 
Malignant mixed 
tumour 
18 9 - - 2 1% 3 3.4 
Acinic Cell 
carcinoma 
      1 1.1 
 
 
According to this table benign tumours are more common 
parotid of which mixed parotid tumour is the commonest. 
Warthin’s tumour occurs in 9% - 36% of all tumours. Of the 
malignancies mucoepidermoid carcinoma is present in 9-21% of 
the tumour. 
 
 
SUBMANDIBULAR GLAND TUMOURS 
Type Conley  et al., 
1972 
N=115 
Spiro    
et al., 
1975 
N=217 
Pinkston 
& Cole 
1999 
N=36 
Vargas 
PA et al 
2002 
N=30 
Benign 53% 44% 78% 80% 
Malignant 47% 56% 22% 20% 
 
This table shows that in all studies, benign tumours are 
more common in submandibular glands. 
INCIDENCE OF SUBMANDIBULAR GLAND 
MALIGNANCIES 
Type Conley  
et al., 
1972 
N=115 
Spiro    
et al., 
1975 
N=217 
Pinkston 
& Cole 
1999 
N=36 
Vargas 
PA et al 
2002 
N=6 
Adenoid Cystic Ca 40 31 35 4 
Adeno Carcinoma 0 15 12 1 
Mucoepidermoid Ca 10 31 19 1 
 
 
Among the malignancies of the submandibular gland, 
adenoid cystic carcinoma is more common. 
 
 
MATERIALS, METHODS AND OBSERVATION 
 
In this study, 34 consecutive patients with parotid and 
submandibular tumors who underwent surgery between 2006 – 
2009 were studied. 
Various clinical manifestations of salivary gland tumours 
were analysed. Age, Sex, duration of illness, involvement of 
adjacent structure, histopathological nature of the tumour were 
studied. Based on the histopathological type treatment was 
planned. Post Operative morbidity and mortality were studied. A 
proforma was devised and cases were followed. 
AGE INCIDENCE 
Parotid Submandibular 
Age Total No. 
cases % 
Total No. 
cases % 
0 – 20 4 13.7 3 60 
21 – 30 7 24 2 40 
31 – 40 5 17.2   
41 – 50 6 20.6   
51 – 60 3 10.3   
61 – 70 3 10.3   
>70 1 3   
 
 
SEX INCIDENCE 
Parotid Submandibular 
Sex Total No. 
cases % 
Total No. 
cases % 
Male 16 55.1 3 60 
Female 13 44.9 2 40 
 
Thus in our study, parotid tumours are common in 3rd to 
5th decade with male predominance. Submandibular tumours 
are mostly in younger age group, also with male predominance. 
CLINICAL MANIFESTATION OF PAROTID TUMOURS 
Symptoms Total No. of Cases % 
Swelling 29 100 
Pain 3 10.3 
 
Thus in main presentation is swelling of the glands and 
pain is present in present in only 3 cases. 
 
 
 
Signs Total No. of  Cases % 
Facial nerve 
involvement 
3 10.3 
Lymphnode 
involvement 
- - 
Muscle involvement - - 
Deep lobe 
involvement 
- - 
 
In the present study out of 29 cases of parotid tumours, 
facial nerve involvement was present in 3 cases at presentation, 
of which all the three cases were found malignant. There was no 
lymph node involvement. There was no deep lobe involvement. 
CLINICAL MANIFESTATION OF SUBMANDIBULAR 
TUMOURS 
Symptoms Total No. of Cases % 
Swelling 5 100 
Pain 2 40 
 
In submandibular tumours, all the cases presented with 
swelling, of which two had vague pain. 
  
HISTOPATHOLOGICAL INVESTIGATION 
FINE NEEDLE ASPIRATION CYTOLOGY : In the present 
study out of 29 parotid tumours, FNAC was done in 15 cases. 
Out of 5 submandibular lesions FNAC was done in all the 5 
cases. 
TECHNIQUE 
The skin is cleaned with spirit. A 22 G needle attached to a 
20ml syringe is used for aspiration. The area to be aspirated is 
fixing with thumb and index finger of one hand. The needle with 
syringe is inserted into the mass with a single quick motion 
without negative pressure in the syringe. Then negative pressure 
is created by retracting the plunger of the syringe. 
The needle is moved back and forth several times into 
different areas of the mass maintaining the negative pressure 
throughout. The plunger is released to equalize the pressure, 
needle is withdrawn and pressure applied over the puncture 
site. The content of the needle lumen is expelled on a series of 
glass slides, smeared, air dried and stained with Hematoxylin 
and Eosin stain. 
 
FNAC FINDINGS  
Parotid 
Total 
Benign Malignant 
Total FNAC +ve Total FNAC +ve 
29 Cases 15 12         
80% 
5 5          
100% 
 
FNAC was done only in 20 out of 29 parotid tumours of 
which 12 were benign, 5 were malignant and 3 were 
inconclusive. 
Submandibular 
Benign Malignant 
Total FNAC +ve Total FNAC +ve 
5 5 
100% 
0 0 
 
In submandibular tumours all the 5 cases underwent 
FNAC and all found to be benign tumour. 
OPERATIVE MANAGEMENT 
Procedure No. of Cases % 
Superfical 
Parotidectomy  
24 88.8 
Total Parotidectomy 3 11.1 
 
 
In the present study Superficial parotidectomy was done in 
24 of cases. Total parotidectomy was doen in 3 out of 5 cases. 
Two patients refused surgery. 
POST – OP COMPLICATIONS 
After parotid Surgery, 
Complication No. of Cases % 
Facial Nerve 
Paralysis 
         Transient 
         Permanent 
 
 
5 
1 
 
 
18.5 
3.7% 
Salivary Fistula - - 
Frey’s Syndrome - - 
 
Following surgery, 5 patients developed transient facial           
nerve paralysis and one patient developed permanent facial 
nerve paralysis. 
There was no complication following submandibular gland 
excision. 
 
DISCUSSION 
 
The parotid, submandibular, and sublingual glands 
constitute the major salivary gland. When functioning properly 
the glands are rarely noticed but when involved with neoplastic 
disease, they can be a challenge in diagnosis and treatment. 
In this study, the parotid, submandibular tumours were 
analysed. Age, Sex incidence, histopathologic type and various 
treatment modalities were analysed in particular reference to 
FNAC, surgical treatment and post-operative complication 
mainly of the facial nerve injury. 
AGE INCIDENCE 
PAROTID 
Age Witt 1999 Study 
% 
Present Study % 
2006-09  
0 – 20 3 13.7 
21 – 30 3 24 
31 – 40 17 17 
41 – 50 17 20 
51 – 60 29 10 
61 – 70 22 10 
>70 8 3 
 
The neoplasms of the parotid is more common in 3rd -7th 
decade. In our study also the parotid tumours are more common 
in 3rd-6th decade. 
In the present study, submandibular tumour occur in 2nd 
and 3rd decade. 
Astor 2002 Present Study  
2006-09 Types Male 
% 
Female 
% 
Male 
% 
Female 
% 
Benign Mixed 
tumour 
4 31 41 41 
Warthin’s tumour 12 4 3 - 
Carcinoma 21 8 11 3 
 
Previously reported studies show the incidence rate of 
salivary neoplasms varied considerably by sex. The male : female 
incidence ratio for benign mixed tumour showed predominance 
of female patients. In the present study, incidence in both the 
sexes is equal. 
Previous studies showed that the male incidence for 
Warthin’s tumour, was more than double that of female 
patients. In this present study the Warthin’s tumour is reported 
in only one male patient. 
Incidence rate of all malignant tumour was more than 3 
times in males to that of female patients. In this present study 
also we noticed higher incidence of carcinoma in males. 
 
ROLE OF FNAC 
Salivary glands form an important area for aspiration 
because, 
1. Glands are eminently accessible 
2. Material is obtained easily 
3. Complications are nil 
4. Incisional biopsy is contraindicated because of risks of 
fistula. 
5. Good diagnostic accuracy can be achieved with experience         
(90-95%). 
The decision regarding surgical therapy of salivary gland 
tumours depends mainly on the histopathologic identity of the 
tumours. Either open biopsy or large bore needle biopsy of 
salivary gland tumour is undesirable because of the risk of 
secondary tumours into the wound or needle track. Experience 
has shown however the fine needle (22 Gauge) aspiration 
cytology does not result is seeding and this has become useful in 
pre-op diagnosis.  
Jayaram and others reported on FNAC cytologic findings of 
247 salivary gland lesions. They reported sensitivity and 
specificity rates of 87.8% and 98% respectively for the detection 
of malignant tumours. 
Pitts and collegues found the diagnostic sensitivity of 
FNAC was only 58% for cancer of the salivary gland. Heller and 
other state the sensitivity for the diagnosis of benign salivary 
gland tumour ranges from 88% to 98% with a specificity of 94%. 
The sensitivity for the detection of malignant tumours of salivary 
glands ranges from 58% to 96%, with specificity of 71% to 88% 
Additionally, FNAB is not very accurate in differentiating among 
the various types of malignant tumour with a specific accuracy 
of only 27% to 85%. 
Study Sensitivity Specificity 
Jayaram et al., 
1994 
87.8% 98% 
Heller et al., 1992 88-98% 94% 
Present Study 88% 100% 
 
In our study FNAC was conducted in 15 out of 24 benign 
parotid tumour and was positive in 12 cases (80%) and 
inconclusive in 3 cases of all the 5 malignancies FNAC was 
positive in all the 5 cases (100%). In all the 5 submandibular 
tumours FNAC was conducted and all the 5 reports showed 
benign tumours MPT (Benign Mixed tumour) (100%) 
Classification Hugo et al., 
Witt 
1999 
Pinkston 
and Cole 
Vargas 
PA et al 
Present 
Study 
1973 
N=917 
 
N=53 1999 
N=212 
2002 
N=88 
2006-09 
No % No % No % No % No % 
Pleomorphic  
Adenoma 
8 4 17 32 113 53 58 66 22 75.8 
Warthin’s Tumour 18 9 19 36 60 28 13 14 1 3.4 
Mucoepidermoid Ca - - 1 2 19 9 9 10 4 13.7 
Adenoid cystic Ca 12 6 - - 1 0.5 - - 1 3.4 
Malig Mixed tumour 18 9 - - 2 1% 3 3.4 - - 
Acinic cell carcinoma       1 1.1   
 
 
In the present study MPT was diagnosed in 76% of parotid 
cases. All of them had undergone Superficial Parotidectomy. 
Follow up showed no incidence of recurrence. The recurrence 
rate of mixed tumours offered in the literature vary widely. The 
primary reasons of recurrence is inadequate removal at the 
onset (i.e enucleation versus removal of a margin of uninvolved 
gland). The tumours persist or recur, because pseudopod or 
parts of the tumour are not removed at the operation, due to 
neglect or fear of damaging the facial nerve. Rupture or seeding 
or other seasons. Adequate surgical removal i.e., atleast 
superficial parotidectomy must be performed. For tumours deep 
to the facial nerve, the procedure of total conservative 
parotidectomy is performed by removal of the portion of the 
gland deep to the nerve, with preservation of the nerve and its 
branches. 
 
In our study Warthin’s tumour is encountered in 1 case, 
(3%) of tumours, which underwent Superficial Parotidectomy. 
Previous reports indicate the presence of Warthin’s tumour 
almost exclusively in parotid gland which occurred between 4th 
and 7th decades. In our study the tumour occurred in the 4th 
decade. 
In the present study, monomorphic adenoma was reported 
in only one case which underwent superficial Parotidectomy. 
In our study malignancy is reported in 5 cases, out of 
which 3 had undergone Total Parotidectomy and the other 2 
cases refused surgery. 
Two cases of mucoepidermoid carcinoma with Pre-
operative facial nerve involvement underwent Total 
parotidectomy. 
One case diagnosed as adenoid cystic carcinoma with 
facial nerve palsy underwent Total Parotidectomy. In the 
previous study also, due to its strong tendency to invade nerves 
and perineural lymphatics facial nerve involvement was high 
(30%), because of which it has poor prognosis. In our study, the 
incidence of adenoid cystic Ca was 3% which co-relate with the 
previous studies. 
SUBMANDIBULAR GLAND TUMOURS 
Type Conley 
et al., 
1972 
Spiro 
Et al., 
1975 
Pinkston 
& Cole 
1999 
Vargas 
PA et al 
2002 
Present 
Study 
2006-09 
Benign 53% 44% 78% 80% 100% 
Malignant 47% 56% 22% 20% - 
 
Of the 34 salivary gland tumours, 5 cases were diagnosed 
as submandibular tumours, of which all were benign mixed 
tumour. 
In the previous studies 5% of tumours were seen in 
submandibular gland of which 50% are malignant. In our study 
14% of tumours occurred in submandibular glands of which all 
are benign tumours. FNAC was done in all the 5 cases, of which 
all showed benign mixed tumour.                                                                       
POST OPERATIVE COMPLICATION  
The most feared complication after parotidectomy is facial 
nerve paralysis, which is reported to be 3 – 5% permanently and 
transient facial nerve palsy is reported to be 8.2 to 65%. (Mehle 
et al., 1993.) 
 
 
 Facial N Palsy  % 
Dallera et al 1993 1.4 
MRA et al 1993 2.1 
Witt 2002 18 
Present study 2006-09 8.8 
 
 
In our study, permanent facial palsy is seen 1 case (4%) 
and transient facial palsy in 5 cases (20%). 
This is mainly because identification of the facial nerve was 
carried out by identifying mastoid process initially as its spatial 
relation to the nerve trunk is constant. So in the firth step of 
superficial parotidectomy the trunk is identified first the plane of 
dissection maintained immediately on the anterior surface of the 
mastoid process as no vital structure lies between the fingerstip 
and the stem of the seventh nerve. 
Many techniques have been proposed over the years for 
accomplishing parotidectomy with identification and 
preservation of the facial nerve and its five or more major 
branches. Full knowledge of the anatomy is essential for safe 
surgery on this gland (Beahrs 1977). 
 
 
 
CONCLUSION 
 
In this study age, sex incidence, histopathological type, 
and various treatment modalities of parotid and submandibular 
gland tumour were analysed in particular reference to Fine 
Needle Aspiration Cytology and surgical treatment. 
The parotid gland tumours are common on 3rd – 6th decade 
and submandibular gland tumours are noticed in 2nd and 3rd 
decade. 
The incidence of benign mixed tumours of parotid is equal 
in both the sexes. Warthin’s tumour was noticed only in male 
patient. The incidence of malignant tumour is common in male 
patients. 
Fine Needle Aspiration Cytology (FNAC) of the parotid 
gland was positive in all malignant cases. In benign tumours it 
was positive in 80% of cases. In rest of the cases it was 
inconclusive. 
In submandibular gland tumours it was positive in all 
benign tumours. 
 
 
No complication was encountered following FNAC. So it 
has go a definitive role in pre-operative diagnosis of all 
malignant tumours of parotid gland and submandibular 
gland tumours. This simple and effective procedure with 
high specificity and sensitivity can be recommended in all 
salivary gland tumours. 
In tumours of the parotid gland, post-operative facial nerve 
palsy was rarely noticed. 
The best means of reducing iatrogenic facial nerve 
injury in parotid surgery remains a keen understanding of 
the anatomy coupled with a gentle technique.  
                                                                           
 
 
 
 
 
 
 
 
 
 
 
 
 
MASTER CHART 
 
S. 
No. 
Name Age/Sex IP No. FNAC/ 
Results 
Pathology Managemen
1. Kamrunisha 58 F 041675 FNAC +ve Mixed Parotid Tumour SuperficialParotidectom
2. Mahalakshmi 36 F 036876 FNAC +ve Mixed Parotid Tumour SuperficialParotidectom
3. Basha 24 M 016864 FNAC +ve Monomorphicadenoma SuperficialParotidectom
4. Arunachalam 43 M 042868 FNAC not done Mixed Parotid Tumour 
Superficial
Parotidectom
5. Krishnamurthy 38 M 040890 FNAC not done Mixed Parotid Tumour 
Superficial
Parotidectom
6. Arul 41 M 036214 FNAC +ve Adeno Lymphoma SuperficialParotidectom
7. Ramarajan 24 M 041631 FNAC not done Mixed Parotid Tumour 
Superficial
Parotidectom
8. Raja 29 M 044618 FNAC –ve Mixed Parotid Tumour SuperficialParotidectom
9. Shankar 19 M 036030 FNAC +ve Mixed Parotid Tumour SuperficialParotidectom
10. Lakshmi 34 F 032312 FNAC not done Mixed Parotid Tumour 
Superficial
Parotidectom
11. Kaliammal 66 F 031670 FNAC +ve Mixed Parotid Tumour SuperficialParotidectom
12. Rani 25 F 023667 FNAC +ve Mixed Parotid Tumour SuperficialParotidectom
13. Balaji 24 M 026874 FNAC not done Mixed Parotid Tumour 
Superficial
Parotidectom
14. Maheswari 24 F 036817 FNAC +ve Mixed Parotid Tumour SuperficialParotidectom
15. Rajadurai 43 M 016817 FNAC -ve Mixed Parotid Tumour SuperficialParotidectom
16. Rajammal 
68 F 026184 
FNAC not 
done 
 
Mixed Parotid Tumour SuperficialParotidectom
17. Arasamma 63 F 036572 FNAC not done Mixed Parotid Tumour 
Superficial
Parotidectom
18. Siva 21 F 036849 FNAC +ve Mixed Parotid Tumour SuperficialParotidectom
19. Anandhi 29 F 038607 FNAC +ve Mixed Parotid Tumour SuperficialParotidectom
20. Rajathi 38 F 021476 FNAC not done Mixed Parotid Tumour 
Superficial
Parotidectom
21. Sakthi 17 M 026712 FNAC not done Mixed Parotid Tumour 
Superficial
Parotidectom
22. Karpagam 39 F 016781 FNAC -ve Mixed Parotid Tumour SuperficialParotidectom
23. Suguna 48 F 061721 FNAC +ve Mixed Parotid Tumour SuperficialParotidectom
24. Kumaresan 17 M 012161 FNAC +ve Mixed Parotid Tumour SuperficialParotidectom
25. Najeema 49 F 031612 FNAC +ve Mucoepidermodia Ca - 
26. Varadan 
34 M 04858 FNAC +ve Mucoepidermodia Ca Total Parotidectom
27. Meenakshi 
46 F 016178 FNAC +ve Adenoid Cystic Ca Total Parotidectom
28. Rajasekar 
50 M 041262 FNAC +ve Muco epidermodi Ca Total Parotidectom
29. Kannan 44 M 041265 FNAC +ve Muco epidermodi Ca - 
30. Rajaraman 18 M 036812 FNAC +ve Benign Mixed Tumour Excision 
31. Manivelan 20 M 061362 FNAC +ve Benign Mixed Tumour Excision 
32. Susheela 26 F 036316 FNAC +ve Benign Mixed Tumour Excision 
33. Mahesh 30 M 026431 FNAC +ve Benign Mixed Tumour Excision 
34. Rukmani 16 F 013125 FNAC +ve Benign Mixed Tumour Excision 
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PROFORMA 
Name :      Age/Sex :    IP. No. 
DOA :      DOO :    DOD : 
History  
 
Clinical Features     Investigations : 
FNAC 
 
 Diagnosis 
Procedure Done ; 
Post OP Complications 
Recognition of Facial Nerve Palsy 
Management of Facial Nerve Palsy 
Follow up 
 
 
 
SALIVARY GLAND TUMOUR INCIDENCE 
PRESENT STUDY 2006-09
85.2%
14.7%
Parotid Submandibular
